Objectives: The aim of the study was to estimate the prevalence of silent ischaemia in diabetic subjects in the population, to compare the prevalence of silent ischaemia in diabetics and non-diabetics and to attempt to predict the presence of silent ischaemia in diabetic subjects. Methods: A random sample of 120 users of insulin and 120 users of oral hypoglycaemic agents aged 40-75 years living in the Danish municipality of Horsens were asked to participate in the study. Corresponding to the youngest half of the sample two non-diabetic controls were randomly selected from the Central Population Register. ST-depression of horizontal or descending character of at least 0.1 mV measured 80 ms after the J-point on either exercise ECG or Holter ECG was considered indicative of myocardial ischaemia. Angina pectoris was considered present if the Rose questionnaire was positive, or chest pain was registered simultaneously with ECG evidence of ischaemia. Individuals with ischaemia, but without angina pectoris, were defined as persons with silent ischaemia. Results: Seventy-four Ž . percent of the invited group were included. The observed prevalence of silent ischaemia in diabetics was 13.5% 95%CIs 8.5-19.8% . Ž . Ž . No association was found between silent ischaemia and gender P s 0.83 or diabetes type P s 0.67 . In the group of diabetics who had Ž . controls, the prevalence was 11.4%, and among the controls the prevalence was 6.4% OR s 1.87, one-sided P s 0.079 . Systolic blood Ž . pressure was highly predictive of silent ischaemia in the diabetic subjects P s 0.005 . No predictive value could be shown for other variables. Conclusion: This is the first population-based study of silent ischaemia in diabetes. The prevalence of silent ischaemia in diabetic subjects was 13.5%. The frequency of silent ischaemia did not differ significantly between diabetics and non-diabetics. Systolic blood pressure was predictive of silent ischaemia in diabetes.
Introduction
Ž . Ischaemic heart disease IHD is the major cause of morbidity and mortality in diabetes, and the prognosis of w x IHD is worse in diabetics than in non-diabetics 1 . Since Ž . IHD is more often met in diabetes, silent ischaemia SI may also be more prevalent. In the general population SI as expressed by electrocardiographic changes during exerw x w x cise testing 2-4 or Holter recordings 5 have been shown to predict the development of symptomatic IHD and death. Thus, diabetics with SI are probably a group at especially high risk of future ischaemic events and will potentially benefit from treatment. In diabetic subjects SI has so far ) Corresponding author. Tel.: q45 66113333; fax: q45 66118796.
only been studied in hospital-based groups. The frequency w x of SI varied in these investigations from 17 to 41% 6-11 w x w x and some authors 12-14 but not all 15,16 found a higher frequency of SI in diabetics than in non-diabetics. To our knowledge, no study has previously tried to assess if the presence of SI can be predicted from other clinical characteristics in diabetic patients.
The aim of this study was threefold: firstly, to estimate the prevalence of SI as expressed electrocardiographically in medically treated diabetic subjects in the general population; secondly, to test if the prevalence of SI is higher in diabetics than in non-diabetics; and thirdly, to attempt to predict the presence of SI in the diabetic population based Time for primary review 33 days.
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Ž . PII S 0 0 0 8 -6 3 6 3 9 7 0 0 0 4 6 -1 ( )on known coronary risk factors. As we wanted to concentrate on individuals in whom coronary artery sclerosis was likely to be present and to whom at the same time a variety of treatment modalities could still be offered, we focused on patients 40-75 years old.
Methods

Participants
To be able to draw a random sample from the diabetic population in the municipality of Horsens, Denmark, the diabetic part of the population was delineated by the prescription method. From November 1 st , 1992, data from prescriptions for antidiabetic medicine were registered. On July 1st, 1993, 740 users of antidiabetic medicine were registered, giving a prevalence of medically treated diabetes mellitus in the municipality of 1.3%. An age-and gender-stratified sample of 120 users of insulin and 120 users of oral hypoglycaemic agents aged 40-75 years was randomly drawn from the database, and 74% were in-Ž . cluded in the study Fig. 1 . The diagnosis of diabetes w x mellitus, according to the criteria of WHO 17 , was confirmed in all subjects. In the insulin-treated group 71 had a fasting C-peptide below 0.30 nmolrl and were Ž . classified as insulin-dependent IDDM . The remaining Ž . diabetics had non-insulin-dependent diabetes NIDDM .
SI is detected in approximately 50% in groups with w x angina 18,19 but only in 1.7-3.2% of asymptomatic w x persons 2,20,21 , indicating that the frequency of SI is positively related to the degree of coronary heart disease. Since the prevalence of ischaemic heart disease in diabetics compared to non-diabetics is higher in the middle-aged w x group than in older persons 22 , we assumed that the ratio of the prevalence of SI in diabetics compared to non-diabetics would also be higher in the middle-aged group. Therefore, in order to raise the efficacy of the study, the control group was matched to the youngest half of the diabetic sample. Since the prevalence of SI was expected to be lower in the control group, we decided to include two controls for each corresponding diabetic to improve the precision of the estimate in the non-diabetic group. The diabetic group was divided into 4 groups according to Ž gender and treatment with insulin median age: females 56 . years, males 52 years or oral hypoglycaemic agents Ž . median age: females 66 years, males 64 years . For each person in the youngest half of these 4 groups 2 age-and gender-matched control persons were randomly selected from the Central Population Register. Ninety-seven diabetics responded, and correspondingly 194 controls were included. To exclude diabetes in the control group, an oral glucose tolerance test was employed.
Methods
The participants were asked if they or one of their parents had ever had a myocardial infarction, about leisure Ž exercise, smoking habits and angina pectoris Rose quesw x. tionnaire 23 . From precoded forms the questions were read aloud to each participant. A history of previous myocardial infarction was only accepted for analysis if verified by hospital records.
A fasting blood sample was taken at 8 a.m. Blood Ž . glucose was measured enzymatically Cobas Mira, Roche , Ž C-peptide analysed radio-immunologically antibody K6, . Novo Nordisk , cholesterol measured enzymatically Ž . CHOD-PAP and haemoglobin A1c quantitated photomet-Ž . rically Waters HPLC . A morning clean-catch midstream urine specimen was tested for nitrite and leukocyte es-Ž terase activity with a dipstick Boehringer Mannheim, . LN . If any of the two reagent squares responded, the urine was cultured and in the case of significant bacteriuria, antibiotics were given. As soon as the urine was dipsticknegative, 3 overnight urines were collected. The urine albumin excretion rate was evaluated by turbidimetry Ž . Cobas Mira .
Standard two-dimensional projections and motion mode were obtained with a Toshiba SSA-140A machine and a 2.5 MHz phased array transducer. Transmitral flow velocities were recorded by pulsed wave Doppler, the sampling depth being adjusted corresponding to the maximal excursion of the anterior mitral leaflet. With continuous wave Doppler, the beam going through the left ventricle outflow tract as well as the anterior mitral leaflet, a trace depicting both the left ventricle outflow and inflow was recorded. Isovolumetric relaxation time was registered from the end of left ventricle outflow to the start of next inflow. In the case of a homogeneous contraction pattern of the left ventricle, the ejection fraction was calculated from the w x motion mode readings 24 , but if regional dyskinesia was present, the ejection fraction was assessed from wall mow x tion index using the 9-segment model 25 . The mass of the left ventricle was calculated from the motion mode w x readings 26 . All recordings were carried out in the expira-( )tion phase, and the mean of 2 readings was used in the calculations.
To avoid observer-induced bias, all manually measured blood pressure values were recorded with a Hawksley w x random zero manometer 27 . The blood pressure was measured twice or more until the difference between 2 consecutive readings was F 4 mmHg, the mean of the 2 being used in the calculations. After at least 10 min in the supine position resting blood pressure was measured. An Ž . ambulatory blood pressure recording TM2420 with auscultatory readings every 30 min for 24 h was carried out.
A maximal symptom-limited bicycle ergometer exercise test was accomplished. The workload was initially 25 W, but increased by 25 W every 2 min. Prior to and each minute during the test, a standard 12-lead ECG was obtained, and the participants questioned about possible chest pain. If present, the pain was quantitated according to the w x Borg scale 28 . Blood pressure was measured manually before, every 2 min during and 1, 2, 4 and 6 min after exercise. Horizontal or descending ST-segment depression of at least 0.1 mV measured 80 ms after the J-point in 3 consecutive cycles was considered a significant sign of ischaemia. If ST-depression was present on the resting ECG, an additional 0.1 mV was required. The ECGs were blinded by a random number before they were interpreted.
Twenty-four-hour Holter ECG recordings of lead CM3 and CM5 were performed using a calibrated amplitude-Ž . modulated 2-channel tape recorder Tracker Reynolds . If a pathological Q-wave was present in any of the 2 leads, the exploring electrode was moved to a position without a Q-wave. The tapes recorded were blinded and analysed by Ž a trained technician at 60 times real time Pathfinder II . analyser, Reynolds , and separate trend curves of ST-segment changes and heart rate were obtained. When the trend curve showed ST-depression, a printout of the ECG at 25 mmrs was obtained for final evaluation. Similar to the exercise ECG, horizontal or descending ST-segment depression of at least 0.1 mV measured 80 ms after the J-point in 3 consecutive cycles was considered a significant sign of ischaemia. During the Holter recording the participants kept a detailed diary in which the degree of chest pain according to the Borg scale was registered, if present.
Angina pectoris was present if the Rose questionnaire was positive or chest pain was registered simultaneously with a recorded ischaemic episode, whether exercise-induced or Holter-detected.
An individual with SI was defined as a person with electrocardiographically proven ischaemia, either exercise-induced or detected by Holter recordings, but without angina pectoris.
Ethics
The study complies with the declaration of Helsinki II, and the study protocol was approved by the local ethics committee. Written informed consent was obtained from each participant after verbal and written information had been given. The results of each individual examination were forwarded to the participant as well as the general practitioner and in the case of any abnormal results, the participant was offered a consultation at the hospital.
Statistics
Calculation of the sample size was based on a risk of a Ž . type-1 error of 0.05 one-sided , a type-2 error of 0.20, an expected prevalence of SI in the control group of 0.025 w x 2,20,21 , a minimal relevant difference of 0.075 and an expected inclusion rate of approximately 0.85.
As the distribution of the majority of the continuous variables was positively skewed, the medians are given and the variation expressed as percentiles or range. Differences between groups were tested with the Mann-Whitney test in case of continuous variables and by the chi-squared test in the case of proportions. Because no study has described a lower frequency of IHD or SI in diabetics than in non-diabetics, we tested if the prevalence of ischaemia, symptomatic or silent, was equal to or higher than that in the diabetics and consequently used a one-sided test. When the P-value given is one-sided, it is always indicated in the text. The corresponding two-sided P-value can be attained by multiplying the one-sided value by 2. Multiple logistic regression analysis to assess the association between SI and possible predictor variables was carried out in 2 steps. In the basic model, the association between SI and 5 variables with an established predictive value with regard w x to symptomatic ischaemic heart disease 29 , was assessed. This model was enhanced with other possible predictor variables one at a time. The risk of a type-1 error of 0.05 was accepted.
Results
Basic characteristics
Blood pressure values, resting as well as ambulatory recordings, were higher in diabetic subjects than in controls, the differences being statistically significant except for the ambulatory diastolic readings. The body mass index was higher in the diabetes group, and the diabetic subjects had a higher frequency of angina pectoris and myocardial Ž . infarction Table 1 .
Echocardiography
The systolic function of the left ventricle was poorer in the diabetes group, whether judged by the ejection fraction Ž . DM s 0.76, non-DMs 0.77; P s 0.024 or the mitral Ž septal separation DM s 4.2 mm, non-DMs 2.9 mm; P -. 0.0001 . The diastolic function of the left ventricle, as 
ms, non-DMs 104 ms; P s 002 , were also reduced in the diabetics. Finally, the calculated mass Ž of the left ventricle was higher among the diabetics DM . s 166 g, non-DMs 147 g; P s 0.036 .
PreÕalence of SI
The exercise test could not be performed in 14 partici-Ž pants 3 atrial fibrillation, 1 aortic stenosis, 2 amputation of a leg, 2 hemiparesis, 4 arthritis of hip or knee and 2 . impaired cooperation . Chest pain was more frequent in Ž . diabetics than in controls Table 2 . No significant difference was found between the groups with regard to exercise-induced ischaemia, silent or symptomatic.
The ST-segment analysis could be carried out in all Ž Holter recordings except for 7 cases 3 left bundle branch . block, 3 atrial fibrillation and 1 technical error . No person had chest pain coinciding with ST-depression. The prevalence of SI was higher in the diabetes group than in the control group, although the level of statistical significance Ž . was not reached odds ratio s 2.61, one-sided P s 0.073 .
Of 173 diabetic subjects who had an exercise test andror a Holter tape that could be analysed, 17 had angina pectoris. In the remaining 156 persons 21 had SI. The Ž prevalence of SI in all diabetics therefore was 13.5% 95% . confidence limits s 8.5-19.8% . Among diabetics with controls the prevalence was 11.4% compared to 6.4% in Ž . the control group odds ratio 1.87, one-sided P s 0.079 . The prevalence of SI was 14.1% in females and 12.9% in Ž . males P s 0.83 . In IDDM the prevalence was 12.2% and Ž . in NIDDM 14.4% P s 0.67 . 
Prediction of SI
Of the 156 diabetics in whom the presence of SI could be assessed, 21 had SI and 135 did not. Differences between these two groups with regard to variables with a Ž . possible predictive value of SI were tested Table 3 . Systolic blood pressure, whether measured at rest or ambulatory, was the only variable examined with a statistically Table 3 one at a time, and none of these variables had a significant independent association with SI. A possible predictive value of albuminuria vanished, when the Ž . association was tested in the multivariate model P s 0.54 . A final multiple logistic regression analysis showed that SI maintained a statistically significant association with am-Ž . bulatory systolic blood pressure P s 0.023 in a model Ž . with ST-depression on the resting ECG P s 0.073 and Ž . left ventricle mass P s 0.98 as the only other variables included. Twenty-four percent of the diabetics with ambu-Ž . latory blood pressure ) 140r90 mmHg had SI 12r50 Ž .Ž compared to 7.8% in the remaining patients 8r102 odds . ratio 3.71, P s 0.0056 . When the diabetes group was divided into quartiles according to their ambulatory systolic blood pressure, a positive relation between the fre- Fig. 2 . Prevalence of silent ischaemia in the diabetes group according to Ž . quartiles of the ambulatory systolic blood pressure ns152 .
quency of SI and blood pressure could be demonstrated Ž . Fig. 2 .
To assess if the association between SI and systolic blood pressure was specifically related to diabetes, we tested this association in the non-diabetic group too. In Ž bivariate analysis no significant relation was found P s . 0.23 , but in the basic logistic regression model again a significant association was present between SI and systolic Ž . blood pressure P s 0.029 , but not between SI and gender Ž . Ž . Ž . Ps0.99 , smoking P s 0.48 , cholesterol P s 0.56 or Ž . age P s 0.12 . 
Discussion
In our population-based sample of 40-75-year-old diabetics treated with insulin or oral hypoglycaemic agents the prevalence of SI was 13.5%. Exercise-induced SI was demonstrated in 8.5% compared with 12.5-31% in previw x ous reports 6-9 . In studies using Holter recordings SI has w x been detected in 14-41% of diabetic subjects 6,10,11 versus 6.9% in the present study. The presence of exercise-induced andror ambulatory SI was demonstrated w x in 29% of diabetics in one report 6 but only in 13.5% in our study. In all previous reports the diabetics have been included from hospital wards or from out-patient clinics. Since referral of diabetics to a hospital milieu probably differs from place to place, the studies cited are unlikely to be comparable, and the results cannot be applied to the population in general. From a theoretical point of view, the average diabetic subject in the general population most likely has fewer diabetic complications including ischaemic heart disease than diabetics needing hospital care. Consequently, it is not surprising that the prevalence of SI in diabetics randomly selected from the general population is lower than the figures found in previous studies.
The prevalence of SI did not differ significantly between the diabetes group and a non-diabetic age-and gender-matched control group. The occurrence of SI was Ž nevertheless higher in the diabetics odds ratio 1.87, one-. sided P s 0.079 , and the lack of statistical significance might be caused by too few participants. When the sample size was calculated, a prevalence of SI of 2.5% in the control group was estimated, but we actually ended up with 6.4%. SI therefore may be more prevalent in the non-diabetic population than previous studies have shown, making the difference between the diabetic and non-diabetic population smaller than anticipated.
Several earlier hospital-based investigations have compared SI between diabetics and non-diabetics and either w x found a higher frequency of SI in diabetics 12-14 or no w x difference 15,16 . The most recent data come from the w x ACIP study 30 which exclusively included patients with angiographically proven coronary artery disease suitable for revascularisation, evidence of stress-related ischaemia and at least one episode of ambulatory silent ischaemia. Additionally the majority of the patients had overt angina pectoris. The authors demonstrated a similar prevalence of SI in diabetics and non-diabetics, but these results cannot be applied to diabetic subjects in the general population.
We showed that systolic blood pressure was strongly and independently associated with SI in diabetic patients, and this observation was made whether resting or ambulatory readings were used in the analysis. Elevated blood pressure, however, has been shown to cause ST-depression in the resting ECG as well as hypertrophy of the left ventricle. If a false positive downward deflection in the ST-segment was more often demonstrated in individuals with ST-depression on the resting ECG, one might speculate that the association between SI and systolic blood pressure could be due to hypertrophy or habitual ST-depression. However, when the association between SI and systolic blood pressure was examined with due consideration of confounding factors such as left ventricle mass and ST-depression on the resting ECG, an independent association between SI and systolic blood pressure could still be Ž . demonstrated P s 0.023 . The result of this analysis is therefore consistent with the theory that the higher frequency of SI in diabetics with high systolic blood pressure is actually caused by increased coronary atherosclerosis secondary to the elevated blood pressure. Holter-detected SI is known to be correlated to increases in systolic blood w x pressure due to an increased oxygen demand 31 . Elevated blood pressure, therefore, may induce ischaemia in otherwise non-critical coronary stenosis. Since diabetics have a higher heart rate due to autonomic neuropathy, and thus a relatively shorter time period to perfuse their myocardium, they may be more sensitive to increased afterload than non-diabetics. This could explain why SI seems to be more strongly correlated with systolic blood pressure in diabetes. Other established predictors of symptomatic ischaemic heart disease were not associated with SI in our study. To the best of our knowledge, a similar analysis has not been undertaken in diabetics before, but a survey in the general population of Tromsø in Norway also demonstrated a positive association between exercise-induced SI and sysw x tolic blood pressure 21 . The authors did not find any relation between SI and other coronary risk factors. These observations are similar to our analysis in the non-diabetic group. Whether SI is an independent predictor of future IHD in the general population when the systolic blood pressure is accounted for remains to be clarified.
It is still an unsettled question whether SI should be treated or not. If, however, a specific treatment modality against SI is indicated in the future, it could be advantageous to search for SI in diabetic subjects. In that case, our results indicate that special attention should be given to diabetics with a high systolic blood pressure. At present, diabetic subjects with SI must be regarded as high-risk persons, and all known modifiable risk factors should be intensively treated.
